A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

When it comes to hair loss, there are as many myths about it as there are treatments for it. An expert broke down common ...

HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...

Stress can lead to noticeable hair loss, usually months after a stressful situation occurs. This type of hair loss is ...

New York, United States, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The medical term for hair loss on the head or body is alopecia, sometimes known as hair loss or baldness. The illness may affect anyone ...

This study will evaluate HCW9302 in patients with moderate to severe alopecia areataMIRAMAR, Fla., Feb. 03, 2025 (GLOBE ...

As of 2018, the global alopecia treatment market is expected to reach $3,935 million by 2026, registering a CAGR of 4.6% from 2019 to 2026. WILMINGTON, DE, UNITED STATES, January 29, 2025 ...

ERLANGEN, GERMANY AND VILNIUS, LITHUANIA - Mallia Therapeutics, a German biopharmaceutical company, and Northway Biotech, a ...

In modern medicine, alopecia treatment is essential since It reduces hair loss and encourages growth. Minoxidil, finasteride, corticosteroids, 5-alpha reductase inhibitors, and cyclosporine can ...

With Northway Biotech’s expertise in biologics manufacturing, Mallia aims to enter the multi-billion-dollar alopecia market by delivering a safe and effective topical sCD83 treatment designed to ...

In modern medicine, alopecia treatment is essential since It reduces hair loss and encourages growth. Minoxidil, finasteride, corticosteroids, 5-alpha reductase inhibitors, and cyclosporine can all be ...